世界の潰瘍性大腸炎市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Ulcerative Colitis Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5783 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、潰瘍性大腸炎のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・潰瘍性大腸炎の市場動向 ・企業の競争状況、市場シェア ・潰瘍性大腸炎の種類別市場規模（経口、注射） ・潰瘍性大腸炎の用途別市場規模（病院、ドラッグストア） ・潰瘍性大腸炎の北米市場規模2016-2027（アメリカ、カナダ） ・潰瘍性大腸炎のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・潰瘍性大腸炎のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・潰瘍性大腸炎の中南米市場規模2016-2027（メキシコ、ブラジル） ・潰瘍性大腸炎の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Johnson & Johnson.、AbbVie、Takeda Pharmaceuticals、Roche、Warner Chilcott、Salix Pharmaceuticals/Santarus、Takeda、Ferring Pharmaceuticals、Pfizer、InDeX Pharmaceuticals） ・結論

Anti-inflammatory drugs are often the first step in the treatment of ulcerative colitis. They include: 5-aminosalicylates. Examples of this type of medication includesulfasalazine (Azulfidine), mesalamine (Asacol HD, Delzicol, others), balsalazide (Colazal) and olsalazine (Dipentum).

Market Analysis and Insights: Global Ulcerative Colitis Market
The global Ulcerative Colitis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ulcerative Colitis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ulcerative Colitis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ulcerative Colitis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ulcerative Colitis market.

Global Ulcerative Colitis Scope and Market Size
Ulcerative Colitis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ulcerative Colitis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral
Injection

Segment by Application
Hospital
Drugs Stores

By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Johnson & Johnson.
AbbVie
Takeda Pharmaceuticals
Roche
Warner Chilcott
Salix Pharmaceuticals/Santarus
Takeda
Ferring Pharmaceuticals
Pfizer

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ulcerative Colitis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Ulcerative Colitis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Drugs Stores
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Ulcerative Colitis Market Perspective (2016-2027)
2.2 Ulcerative Colitis Growth Trends by Regions
2.2.1 Ulcerative Colitis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ulcerative Colitis Historic Market Share by Regions (2016-2021)
2.2.3 Ulcerative Colitis Forecasted Market Size by Regions (2022-2027)
2.3 Ulcerative Colitis Industry Dynamic
2.3.1 Ulcerative Colitis Market Trends
2.3.2 Ulcerative Colitis Market Drivers
2.3.3 Ulcerative Colitis Market Challenges
2.3.4 Ulcerative Colitis Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Ulcerative Colitis Players by Revenue
3.1.1 Global Top Ulcerative Colitis Players by Revenue (2016-2021)
3.1.2 Global Ulcerative Colitis Revenue Market Share by Players (2016-2021)
3.2 Global Ulcerative Colitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ulcerative Colitis Revenue
3.4 Global Ulcerative Colitis Market Concentration Ratio
3.4.1 Global Ulcerative Colitis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ulcerative Colitis Revenue in 2020
3.5 Ulcerative Colitis Key Players Head office and Area Served
3.6 Key Players Ulcerative Colitis Product Solution and Service
3.7 Date of Enter into Ulcerative Colitis Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Ulcerative Colitis Breakdown Data by Type
4.1 Global Ulcerative Colitis Historic Market Size by Type (2016-2021)
4.2 Global Ulcerative Colitis Forecasted Market Size by Type (2022-2027)

5 Ulcerative Colitis Breakdown Data by Application
5.1 Global Ulcerative Colitis Historic Market Size by Application (2016-2021)
5.2 Global Ulcerative Colitis Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Ulcerative Colitis Market Size (2016-2027)
6.2 North America Ulcerative Colitis Market Size by Type
6.2.1 North America Ulcerative Colitis Market Size by Type (2016-2021)
6.2.2 North America Ulcerative Colitis Market Size by Type (2022-2027)
6.2.3 North America Ulcerative Colitis Market Size by Type (2016-2027)
6.3 North America Ulcerative Colitis Market Size by Application
6.3.1 North America Ulcerative Colitis Market Size by Application (2016-2021)
6.3.2 North America Ulcerative Colitis Market Size by Application (2022-2027)
6.3.3 North America Ulcerative Colitis Market Size by Application (2016-2027)
6.4 North America Ulcerative Colitis Market Size by Country
6.4.1 North America Ulcerative Colitis Market Size by Country (2016-2021)
6.4.2 North America Ulcerative Colitis Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Ulcerative Colitis Market Size (2016-2027)
7.2 Europe Ulcerative Colitis Market Size by Type
7.2.1 Europe Ulcerative Colitis Market Size by Type (2016-2021)
7.2.2 Europe Ulcerative Colitis Market Size by Type (2022-2027)
7.2.3 Europe Ulcerative Colitis Market Size by Type (2016-2027)
7.3 Europe Ulcerative Colitis Market Size by Application
7.3.1 Europe Ulcerative Colitis Market Size by Application (2016-2021)
7.3.2 Europe Ulcerative Colitis Market Size by Application (2022-2027)
7.3.3 Europe Ulcerative Colitis Market Size by Application (2016-2027)
7.4 Europe Ulcerative Colitis Market Size by Country
7.4.1 Europe Ulcerative Colitis Market Size by Country (2016-2021)
7.4.2 Europe Ulcerative Colitis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Ulcerative Colitis Market Size (2016-2027)
8.2 Asia-Pacific Ulcerative Colitis Market Size by Type
8.2.1 Asia-Pacific Ulcerative Colitis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ulcerative Colitis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ulcerative Colitis Market Size by Type (2016-2027)
8.3 Asia-Pacific Ulcerative Colitis Market Size by Application
8.3.1 Asia-Pacific Ulcerative Colitis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ulcerative Colitis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ulcerative Colitis Market Size by Application (2016-2027)
8.4 Asia-Pacific Ulcerative Colitis Market Size by Region
8.4.1 Asia-Pacific Ulcerative Colitis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ulcerative Colitis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Ulcerative Colitis Market Size (2016-2027)
9.2 Latin America Ulcerative Colitis Market Size by Type
9.2.1 Latin America Ulcerative Colitis Market Size by Type (2016-2021)
9.2.2 Latin America Ulcerative Colitis Market Size by Type (2022-2027)
9.2.3 Latin America Ulcerative Colitis Market Size by Type (2016-2027)
9.3 Latin America Ulcerative Colitis Market Size by Application
9.3.1 Latin America Ulcerative Colitis Market Size by Application (2016-2021)
9.3.2 Latin America Ulcerative Colitis Market Size by Application (2022-2027)
9.3.3 Latin America Ulcerative Colitis Market Size by Application (2016-2027)
9.4 Latin America Ulcerative Colitis Market Size by Country
9.4.1 Latin America Ulcerative Colitis Market Size by Country (2016-2021)
9.4.2 Latin America Ulcerative Colitis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Ulcerative Colitis Market Size (2016-2027)
10.2 Middle East & Africa Ulcerative Colitis Market Size by Type
10.2.1 Middle East & Africa Ulcerative Colitis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ulcerative Colitis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ulcerative Colitis Market Size by Type (2016-2027)
10.3 Middle East & Africa Ulcerative Colitis Market Size by Application
10.3.1 Middle East & Africa Ulcerative Colitis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ulcerative Colitis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ulcerative Colitis Market Size by Application (2016-2027)
10.4 Middle East & Africa Ulcerative Colitis Market Size by Country
10.4.1 Middle East & Africa Ulcerative Colitis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ulcerative Colitis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Johnson & Johnson.
11.1.1 Johnson & Johnson. Company Details
11.1.2 Johnson & Johnson. Business Overview
11.1.3 Johnson & Johnson. Ulcerative Colitis Introduction
11.1.4 Johnson & Johnson. Revenue in Ulcerative Colitis Business (2016-2021)
11.1.5 Johnson & Johnson. Recent Development
11.2 AbbVie
11.2.1 AbbVie Company Details
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Ulcerative Colitis Introduction
11.2.4 AbbVie Revenue in Ulcerative Colitis Business (2016-2021)
11.2.5 AbbVie Recent Development
11.3 Takeda Pharmaceuticals
11.3.1 Takeda Pharmaceuticals Company Details
11.3.2 Takeda Pharmaceuticals Business Overview
11.3.3 Takeda Pharmaceuticals Ulcerative Colitis Introduction
11.3.4 Takeda Pharmaceuticals Revenue in Ulcerative Colitis Business (2016-2021)
11.3.5 Takeda Pharmaceuticals Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Ulcerative Colitis Introduction
11.4.4 Roche Revenue in Ulcerative Colitis Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Warner Chilcott
11.5.1 Warner Chilcott Company Details
11.5.2 Warner Chilcott Business Overview
11.5.3 Warner Chilcott Ulcerative Colitis Introduction
11.5.4 Warner Chilcott Revenue in Ulcerative Colitis Business (2016-2021)
11.5.5 Warner Chilcott Recent Development
11.6 Salix Pharmaceuticals/Santarus
11.6.1 Salix Pharmaceuticals/Santarus Company Details
11.6.2 Salix Pharmaceuticals/Santarus Business Overview
11.6.3 Salix Pharmaceuticals/Santarus Ulcerative Colitis Introduction
11.6.4 Salix Pharmaceuticals/Santarus Revenue in Ulcerative Colitis Business (2016-2021)
11.6.5 Salix Pharmaceuticals/Santarus Recent Development
11.7 Takeda
11.7.1 Takeda Company Details
11.7.2 Takeda Business Overview
11.7.3 Takeda Ulcerative Colitis Introduction
11.7.4 Takeda Revenue in Ulcerative Colitis Business (2016-2021)
11.7.5 Takeda Recent Development
11.8 Ferring Pharmaceuticals
11.8.1 Ferring Pharmaceuticals Company Details
11.8.2 Ferring Pharmaceuticals Business Overview
11.8.3 Ferring Pharmaceuticals Ulcerative Colitis Introduction
11.8.4 Ferring Pharmaceuticals Revenue in Ulcerative Colitis Business (2016-2021)
11.8.5 Ferring Pharmaceuticals Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Ulcerative Colitis Introduction
11.9.4 Pfizer Revenue in Ulcerative Colitis Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 InDeX Pharmaceuticals
11.10.1 InDeX Pharmaceuticals Company Details
11.10.2 InDeX Pharmaceuticals Business Overview
11.10.3 InDeX Pharmaceuticals Ulcerative Colitis Introduction
11.10.4 InDeX Pharmaceuticals Revenue in Ulcerative Colitis Business (2016-2021)
11.10.5 InDeX Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Ulcerative Colitis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Global Ulcerative Colitis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Ulcerative Colitis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Ulcerative Colitis Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Ulcerative Colitis Market Share by Regions (2016-2021)
Table 8. Global Ulcerative Colitis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Ulcerative Colitis Market Share by Regions (2022-2027)
Table 10. Ulcerative Colitis Market Trends
Table 11. Ulcerative Colitis Market Drivers
Table 12. Ulcerative Colitis Market Challenges
Table 13. Ulcerative Colitis Market Restraints
Table 14. Global Ulcerative Colitis Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Ulcerative Colitis Market Share by Players (2016-2021)
Table 16. Global Top Ulcerative Colitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ulcerative Colitis as of 2020)
Table 17. Ranking of Global Top Ulcerative Colitis Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Ulcerative Colitis Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Ulcerative Colitis Product Solution and Service
Table 21. Date of Enter into Ulcerative Colitis Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Ulcerative Colitis Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Ulcerative Colitis Revenue Market Share by Type (2016-2021)
Table 25. Global Ulcerative Colitis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Ulcerative Colitis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Ulcerative Colitis Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Ulcerative Colitis Revenue Market Share by Application (2016-2021)
Table 29. Global Ulcerative Colitis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Ulcerative Colitis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Ulcerative Colitis Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Ulcerative Colitis Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Ulcerative Colitis Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Ulcerative Colitis Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Ulcerative Colitis Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Ulcerative Colitis Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Ulcerative Colitis Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Ulcerative Colitis Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Ulcerative Colitis Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Ulcerative Colitis Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Ulcerative Colitis Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Ulcerative Colitis Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Ulcerative Colitis Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Ulcerative Colitis Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Ulcerative Colitis Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Ulcerative Colitis Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Ulcerative Colitis Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Ulcerative Colitis Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Ulcerative Colitis Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Ulcerative Colitis Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Ulcerative Colitis Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Ulcerative Colitis Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Ulcerative Colitis Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Ulcerative Colitis Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Ulcerative Colitis Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Ulcerative Colitis Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Ulcerative Colitis Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Ulcerative Colitis Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Ulcerative Colitis Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Ulcerative Colitis Market Size by Country (2022-2027) & (US$ Million)
Table 61. Johnson & Johnson. Company Details
Table 62. Johnson & Johnson. Business Overview
Table 63. Johnson & Johnson. Ulcerative Colitis Product
Table 64. Johnson & Johnson. Revenue in Ulcerative Colitis Business (2016-2021) & (US$ Million)
Table 65. Johnson & Johnson. Recent Development
Table 66. AbbVie Company Details
Table 67. AbbVie Business Overview
Table 68. AbbVie Ulcerative Colitis Product
Table 69. AbbVie Revenue in Ulcerative Colitis Business (2016-2021) & (US$ Million)
Table 70. AbbVie Recent Development
Table 71. Takeda Pharmaceuticals Company Details
Table 72. Takeda Pharmaceuticals Business Overview
Table 73. Takeda Pharmaceuticals Ulcerative Colitis Product
Table 74. Takeda Pharmaceuticals Revenue in Ulcerative Colitis Business (2016-2021) & (US$ Million)
Table 75. Takeda Pharmaceuticals Recent Development
Table 76. Roche Company Details
Table 77. Roche Business Overview
Table 78. Roche Ulcerative Colitis Product
Table 79. Roche Revenue in Ulcerative Colitis Business (2016-2021) & (US$ Million)
Table 80. Roche Recent Development
Table 81. Warner Chilcott Company Details
Table 82. Warner Chilcott Business Overview
Table 83. Warner Chilcott Ulcerative Colitis Product
Table 84. Warner Chilcott Revenue in Ulcerative Colitis Business (2016-2021) & (US$ Million)
Table 85. Warner Chilcott Recent Development
Table 86. Salix Pharmaceuticals/Santarus Company Details
Table 87. Salix Pharmaceuticals/Santarus Business Overview
Table 88. Salix Pharmaceuticals/Santarus Ulcerative Colitis Product
Table 89. Salix Pharmaceuticals/Santarus Revenue in Ulcerative Colitis Business (2016-2021) & (US$ Million)
Table 90. Salix Pharmaceuticals/Santarus Recent Development
Table 91. Takeda Company Details
Table 92. Takeda Business Overview
Table 93. Takeda Ulcerative Colitis Product
Table 94. Takeda Revenue in Ulcerative Colitis Business (2016-2021) & (US$ Million)
Table 95. Takeda Recent Development
Table 96. Ferring Pharmaceuticals Company Details
Table 97. Ferring Pharmaceuticals Business Overview
Table 98. Ferring Pharmaceuticals Revenue in Ulcerative Colitis Business (2016-2021) & (US$ Million)
Table 99. Ferring Pharmaceuticals Recent Development
Table 100. Pfizer Company Details
Table 101. Pfizer Business Overview
Table 102. Pfizer Ulcerative Colitis Product
Table 103. Pfizer Revenue in Ulcerative Colitis Business (2016-2021) & (US$ Million)
Table 104. Pfizer Recent Development
Table 105. InDeX Pharmaceuticals Company Details
Table 106. InDeX Pharmaceuticals Business Overview
Table 107. InDeX Pharmaceuticals Ulcerative Colitis Product
Table 108. InDeX Pharmaceuticals Revenue in Ulcerative Colitis Business (2016-2021) & (US$ Million)
Table 109. InDeX Pharmaceuticals Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ulcerative Colitis Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Injection Features
Figure 4. Global Ulcerative Colitis Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Drugs Stores Case Studies
Figure 7. Ulcerative Colitis Report Years Considered
Figure 8. Global Ulcerative Colitis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Ulcerative Colitis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Ulcerative Colitis Market Share by Regions: 2020 VS 2027
Figure 11. Global Ulcerative Colitis Market Share by Regions (2022-2027)
Figure 12. Global Ulcerative Colitis Market Share by Players in 2020
Figure 13. Global Top Ulcerative Colitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ulcerative Colitis as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Ulcerative Colitis Revenue in 2020
Figure 15. Global Ulcerative Colitis Revenue Market Share by Type (2016-2021)
Figure 16. Global Ulcerative Colitis Revenue Market Share by Type (2022-2027)
Figure 17. North America Ulcerative Colitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Ulcerative Colitis Market Share by Type (2016-2027)
Figure 19. North America Ulcerative Colitis Market Share by Application (2016-2027)
Figure 20. North America Ulcerative Colitis Market Share by Country (2016-2027)
Figure 21. United States Ulcerative Colitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Ulcerative Colitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Ulcerative Colitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Ulcerative Colitis Market Share by Type (2016-2027)
Figure 25. Europe Ulcerative Colitis Market Share by Application (2016-2027)
Figure 26. Europe Ulcerative Colitis Market Share by Country (2016-2027)
Figure 27. Germany Ulcerative Colitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Ulcerative Colitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Ulcerative Colitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Ulcerative Colitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Ulcerative Colitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Ulcerative Colitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Ulcerative Colitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Ulcerative Colitis Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Ulcerative Colitis Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Ulcerative Colitis Market Share by Region (2016-2027)
Figure 37. China Ulcerative Colitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Ulcerative Colitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Ulcerative Colitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Ulcerative Colitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Ulcerative Colitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Ulcerative Colitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Ulcerative Colitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Ulcerative Colitis Market Share by Type (2016-2027)
Figure 45. Latin America Ulcerative Colitis Market Share by Application (2016-2027)
Figure 46. Latin America Ulcerative Colitis Market Share by Country (2016-2027)
Figure 47. Mexico Ulcerative Colitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Ulcerative Colitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Ulcerative Colitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Ulcerative Colitis Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Ulcerative Colitis Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Ulcerative Colitis Market Share by Country (2016-2027)
Figure 53. Turkey Ulcerative Colitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Ulcerative Colitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Ulcerative Colitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Johnson & Johnson. Revenue Growth Rate in Ulcerative Colitis Business (2016-2021)
Figure 57. AbbVie Revenue Growth Rate in Ulcerative Colitis Business (2016-2021)
Figure 58. Takeda Pharmaceuticals Revenue Growth Rate in Ulcerative Colitis Business (2016-2021)
Figure 59. Roche Revenue Growth Rate in Ulcerative Colitis Business (2016-2021)
Figure 60. Warner Chilcott Revenue Growth Rate in Ulcerative Colitis Business (2016-2021)
Figure 61. Salix Pharmaceuticals/Santarus Revenue Growth Rate in Ulcerative Colitis Business (2016-2021)
Figure 62. Takeda Revenue Growth Rate in Ulcerative Colitis Business (2016-2021)
Figure 63. Ferring Pharmaceuticals Revenue Growth Rate in Ulcerative Colitis Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Ulcerative Colitis Business (2016-2021)
Figure 65. InDeX Pharmaceuticals Revenue Growth Rate in Ulcerative Colitis Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---